Clinical cases demonstrate successful use of TRAUMAGEL during tourniquet conversion in prolonged field care, including in gunshot wounds, industrial trauma and sharp-force injuries NEW YORK, July 7, 2026 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company...
Hence then, the article about traumagel study highlights sustained hemorrhage control and tourniquet removal without rebleeding was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( TRAUMAGEL Study Highlights Sustained Hemorrhage Control and Tourniquet Removal Without Rebleeding )
Also on site :
- 'Love on the Spectrum' Star Hard Launches New Romance — And Fans Are Shocked by One Trait
- US budget slashing risks losing global scientific edge to China
- X Square Robot Launches QUANXTA Zero Series, Reframing Embodied Data Production Through Universal Manipulation Interfaces